Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-04-001158
Filing Date
2004-02-03
Accepted
2004-02-03 13:13:15
Documents
5
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. y93764e10vq.txt 10-Q 92428
3 302 CERTIFICATION: CEO y93764exv31w1.txt EX-31.1 3440
4 302 CERTIFICATION: CFO y93764exv31w2.txt EX-31.2 3456
5 906 CERTIFICATION: CEO y93764exv32w1.txt EX-32.1 1380
6 906 CERTIFICATION: CFO y93764exv32w2.txt EX-32.2 1406
  Complete submission text file 0000950123-04-001158.txt   104261
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 04561940
SIC: 2835 In Vitro & In Vivo Diagnostic Substances